Top Health Care Stocks
JNJ +0.57%
PFE +1.93%
ABT +0.82%
MRK +0.82%
AMGN +0.54%
Health care stocks were hanging on to moderate gains, including a more than 0.4% advance for the NYSE Health Care Index. Shares of health care companies in the S&P 500 were up over 0.4% as a group although the Nasdaq Biotechnology index was down almost 1.0%.
Among health care stocks moving on news:
+ HMS Holdings ( HMSY ) rose almost 17% to its highest share price since February 2013 after the health care cost-containment platform reported non-GAAP Q2 net income of $0.25 per share on $146.8 million in revenue, up on both sides compared with year-ago levels and also topping Wall Street estimates. The company also raised its revenue forecast by $15 million over its prior outlook to a new range of $575 million to $585 million and now exceeding the Street view by at least $1 million.
In other sector news:
+ Allscripts Healthcare Solutions ( MDRX ) extended its gains Friday afternoon, pushing out to a more than 11% advance after the health care technology company late Thursday reported non-GAAP Q2 net income of $0.18 per share, up from $0.15 per share during the year-ago period and matching the Capital IQ consensus. Non-GAAP revenue rose 25% year-over-year to $535.8 million, narrowly missing the $538.16 million analyst mean.
- Select Medical Holdings Corp ( SEM ) declined Friday after reporting adjusted Q2 net income of $0.31 per share for the three months ended June 30, down from $0.32 per share during the same quarter last year and trailing the Capital IQ consensus by $0.03 per share. Net operating revenues for the acute care hospital chain grew 17.6% year-over-year to just under $1.3 billion, narrowly beating the $1.29 billion Street view.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
